About Enhancer
| Enhancer ID: | E_03296 |
| Species: | Homo sapiens |
| Position : | chr11:2236031-2239626   |
| Year: | 2017 |
| Title: | Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. |
| Genome Build: | hg19 |
| Enhancer Type: | Super-enhancer |
| Condition: | Disease |
| Disease Name: | colorectal cancer |
| PMID: | 27869826 |
| MONDO: | MONDO:0005575 |
| Tissue: | colon |
| Tissue Ontology ID: | UBERON:0001155 |
| Cell Source: | HCT 116 |
| CVCL ID: | CVCL_0291 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; Chromatin interaction assay; Structural-variant enhancer-hijacking assay |
| High Throughput Method: | Pan-cancer SCNA/mRNA-seq/TAD integration; H3K27ac ChIP-seq; 4C-seq; long-insert paired-end sequencing |
| Low Throughput Method: | Dual-luciferase reporter assay in HCT 116 with HeLa control; PCR-based structural-variant validation |
About Target Gene
| Target gene : | IGF2 |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Expression of Target Genes for the Enhancer